Aptar has announced a new collaboration agreement with Chinese connected drug delivery specialist Sonmol for development of an inhaler monitoring system designed to "enable remote patient monitoring, improve patient and physician interactions, increase patient engagement and adherence, and improve health outcomes" in China and other Asian countries. According to the … [Read more...] about Aptar partners with Sonmol for development of digital inhaler monitoring system for Asian market
News
Exhibitors preparing for Digital RDD 2020
With the transformation of RDD 2020 into Digital RDD 2020 due to the COVID-19 pandemic, one of the biggest questions has been whether previously booked exhibitors would still choose to participate in the technology exhibition. According to Richard Dalby, one of the organizers of the meeting, not only have many of the previously booked exhibitors chosen to take part … [Read more...] about Exhibitors preparing for Digital RDD 2020
3P Innovation wins Queen’s Award for Innovation for Fill2Weight powder dosing technology
3P Innovation's Fill2Weight powder micro-dosing system, which was designed specifically for filling dry powder inhalation formulations, has been awarded the Queen's Award for Enterprise in Innovation. The Fill2Weight technology is scalable and can be used for dosing from lab scale to commercial production. In January 2018, 3P announced the launch of its R500/R1000 … [Read more...] about 3P Innovation wins Queen’s Award for Innovation for Fill2Weight powder dosing technology
Adherium partners with Planet Innovation
Adherium has announced a strategic partnership with Australian tech company Planet Innovation for device hardware and software development related to Adherium's inhaler monitoring systems. According to the company, the new deal is "complementary" to the deal with Summatix that was announced in August 2019. The partnership announcement comes shortly after Adherium … [Read more...] about Adherium partners with Planet Innovation
University of Waterloo researchers working on intranasal vaccine against COVID-19
The University of Waterloo has announced that School of Pharmacy faculty members Roderick Slavcev and Emmanuel Ho are collaborating with Chemical Engineering professor Marc Aucoin on development of an intranasal vaccine against COVID-19. According to the announcement, Slavcev is modifying his group's existing bacteriophage vaccine technology for the COVID-19 vaccine … [Read more...] about University of Waterloo researchers working on intranasal vaccine against COVID-19
Enterin announces planned study of inhaled therapy for COVID-19
US-based Enterin Inc. announced that it has been in talks with the FDA in preparation for a Phase 1/2a study of a nebulized formulation of its COV-ENT-1 in patients hospitalized with COVID-19. The company said that it plans to develop a dry powder COV-ENT-1 for inhalation if the study is successful. Enterin's lead candidate, ENT-01 (kenterin), is currently in Phase 2 … [Read more...] about Enterin announces planned study of inhaled therapy for COVID-19
Beyond Air to initiate trial of its LungFit iNO system for COVID-19
According to Beyond Air, the company has received permission from the FDA to initiate a clinical study of its LungFit inhaled nitric oxide system for the treatment of COVID-19 patients. The announcement comes almost a month after the company said that it had submitted an investigational device exemption application to the FDA for that purpose. The company said that it … [Read more...] about Beyond Air to initiate trial of its LungFit iNO system for COVID-19
Pulmatrix licenses NasoCalm to Sensory Cloud for an OTC nasal protection product against COVID-19
Tech start-up Sensory Cloud has acquired an exclusive worldwide license for Pulmatrix salt formulations PUR 003 and PUR 006 (NasoCalm), for purposes of "OTC nasal delivery to potentially reduce the pathogenic risk and transmissibility of contagions, including with respect to COVID-19." Sensory Cloud will pay royalties rising from 7% this year to 14% in 2021 and 17% … [Read more...] about Pulmatrix licenses NasoCalm to Sensory Cloud for an OTC nasal protection product against COVID-19
Hovione Technology’s 8Shot large dose DPI wins Red Dot 2020 Product Design Award
Hovione Technology announced that its 8Shot large dose DPI has won a Red Dot 2020 Product Design Award in the Healthcare Daily Living Aids category. The 8Shot device is an 8-puff, disposable DPI that can deliver total doses of up to 400 mg from 8 pre-filled drug compartments that hold 50 mg each. In August 2019, Hovione Technology announced that it had partnered … [Read more...] about Hovione Technology’s 8Shot large dose DPI wins Red Dot 2020 Product Design Award
TFF Pharmaceuticals enters agreement with US Army for development of dry powder vaccines
TFF Pharmaceuticals said that it has entered into a 3-year Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) for development of dry powder vaccines against alphaviruses such as Eastern equine encephalitis and against filoviruses such as Ebola and Marburg. … [Read more...] about TFF Pharmaceuticals enters agreement with US Army for development of dry powder vaccines